iShares US Pharmaceuticals ETF
IHE
IHE
87 hedge funds and large institutions have $111M invested in iShares US Pharmaceuticals ETF in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 37 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
59% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 37
Holders
87
Holding in Top 10
–
Calls
$2K
Puts
–
Top Buyers
| 1 | +$22.6M | |
| 2 | +$4.91M | |
| 3 | +$2.68M | |
| 4 |
SPIA
Steward Partners Investment Advisory
New York
|
+$817K |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
+$599K |
Top Sellers
| 1 | -$4.36M | |
| 2 | -$4M | |
| 3 | -$2.93M | |
| 4 |
AWA
ARS Wealth Advisors
St. Petersburg,
Florida
|
-$2.55M |
| 5 |
Morgan Stanley
New York
|
-$1.34M |